A, D., S, R., K, M., K, M., & S, K. (2025). Intravitreal Ranibizumab versus Razumab in treatment naïve diabetic macular edema. KIMS Foundation and Research Center.
Chicago Style (17th ed.) CitationA, Dhandapani, Ravindran S, Muthusamy K, Muruganandham K, and Kaliamurty S. Intravitreal Ranibizumab Versus Razumab in Treatment Naïve Diabetic Macular Edema. KIMS Foundation and Research Center, 2025.
MLA (9th ed.) CitationA, Dhandapani, et al. Intravitreal Ranibizumab Versus Razumab in Treatment Naïve Diabetic Macular Edema. KIMS Foundation and Research Center, 2025.
Warning: These citations may not always be 100% accurate.